Previous close | 6.10 |
Open | 7.09 |
Bid | 5.30 |
Ask | 5.70 |
Strike | 180.00 |
Expiry date | 2024-08-16 |
Day's range | 6.10 - 7.10 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Lucid Diagnostic's (LUCD) ESOGUARD BE-1 study data shows high sensitivity and negative predictive value for the EsoGuard test, enhancing early detection of esophageal precancer in a screening population.
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
KORU Medical (KRMD) announces the receipt of regulatory clearance for its FreedomEdge System in Japan.